What is Lucis?
Lucis is a pioneering preventive health company operating in the UK, dedicated to empowering individuals with personalized health insights derived from blood test results. By analyzing key biomarkers, the company provides users with a clear understanding of their health scores and biological age, enabling proactive health management and longevity optimization. Lucis offers a subscription-based service that makes advanced health monitoring accessible without requiring a doctor's referral, positioning itself as a leader in the direct-to-consumer health diagnostics market.
How much funding has Lucis raised?
Lucis has raised a total of $28.5M across 1 funding round:
Seed
$8.5M
Seed (2025): $8.5M, investors not publicly disclosed
What's next for Lucis?
The recent major enterprise-level funding positions Lucis for significant expansion and further development of its platform. This strategic investment is likely to fuel advancements in biomarker analysis, enhance user experience, and broaden market reach within the UK and potentially internationally. The company is poised to capitalize on the increasing consumer demand for personalized health solutions and data-driven wellness, solidifying its role in the preventive health ecosystem.
See full Lucis company page
